ArticleCurrent oncology (Toronto, Ont.)2021

Considerations for Developing a Reassessment Process: Report from the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration's Reassessment and Uptake Working Group.

Wei Fang Dai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.